Загрузка...
Bright-field HER2 dual in situ hybridization (DISH) assay on breast cancer cell blocks: a comparative study with histological sections
BACKGROUND: HER2 testing for samples from recurrent or metastatic disease is recommended by the 2013 update of the American Society of Clinical Oncology/College of American Pathologists (ASCO/CAP) guidelines and cytological analysis can be applied to several types of metastatic lesions. However, the...
Сохранить в:
| Опубликовано в: : | Breast Cancer |
|---|---|
| Главные авторы: | , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Springer Japan
2016
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5082585/ https://ncbi.nlm.nih.gov/pubmed/26746842 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12282-015-0664-1 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|